“treatment resistant depression”的搜索结果，显示 151-160 项，共有 7717 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Onvansertib For The Treatment Of Recurrent Or Refractory Chronic Myelomonocytic Leukemia. Rochester, Minn. This phase I trial evaluates the safety, ...

2. 外科 - 临床试验- 妙佑医疗国际

   A Study Of Acute Stimulation For The Modulation Of Epileptic Events With A Closed-Loop Brain Interchange System In Drug Resistant Epilepsy. Rochester, Minn ...

3. 关于 - 妙佑医疗国际

   CAR-T cell therapy may be recommended when a cancer: Doesn't respond to other treatments, also called refractory cancer. Comes back within 12 months after the ...

4. 血液科- 临床试验- 妙佑医疗国际

   ... Treatments For Adult Patients With Multiple Myeloma That Is Resistant To Current Standard Of Care Treatments. Rochester, Minn. This phase 1b trial is an open ...

5. 外科 - 临床试验- 妙佑医疗国际

   A Study Of Acute Stimulation For The Modulation Of Epileptic Events With A Closed-Loop Brain Interchange System In Drug Resistant Epilepsy. Rochester, Minn ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Remain in long term follow-up for a period of four additional years. Phase 1 Trial Of ST-001 NanoFenretinide In Relapsed/Refractory T-cell Non-Hodgkin Lymphoma.

7. 血液科- 临床试验- 妙佑医疗国际

   ... Treatments For Adult Patients With Multiple Myeloma That Is Resistant To Current Standard Of Care Treatments. Rochester, Minn. This phase 1b trial is an open ...

8. 外科 - 临床试验- 妙佑医疗国际

   ... treatment or patients that are experiencing an ... depression, and perceive high caregiver burden. ... The pupose of this study is to evaluate whether or not ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   PARP inhibitors are a type of targeted therapy. Adding abemaciclib to olaparib may work better to treat recurrent platinum-resistant ovarian cancer. A Study ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    PARP inhibitors are a type of targeted therapy. Adding abemaciclib to olaparib may work better to treat recurrent platinum-resistant ovarian cancer.